Events

Join us for this highly interactive program that provides coaching frameworks to facilitate analysis and group problem solving. This program is offered in collaboration with the VP&S Faculty Advisory Deans and the Virginia Kneeland Frantz Society for Women Faculty and uses situations experienced by faculty at CUIMC across all career paths. Case submissions: Faculty will work together on situations (cases) that are commonly experienced by faculty. These cases are submitted by faculty and de-identified when shared with the group in order to preserve anonymity. Our goal is to provide a new case each session, so please consider submitting a case soon: Submit your cases!    

In this session, experts from Columbia University Herbert Irving Comprehensive Cancer Center will share updates in the treatment of acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL), including newly approved therapies and treatment options such as cell therapies. In addition, issues in allogeneic transplant for AML will be discussed, including strategies like micro-transplant and new approaches for GVHD treatment. New directions in treatment in terms of ongoing clinical trials in AML and ALL will also be shared. Target audience – medical oncologists, trainees, other allied health professionals. Updates on the Treatment of AML Joseph G. Jurcic, MD, Professor of Medicine at CUMC; Director, Hematologic Malignancies Section, Columbia University Vagelos College of Physicians and Surgeons Issues in Allogeneic Transplant for AML Markus Y. Mapara, MD, PhD, Professor of Medicine, Columbia University Vagelos College of Physicians and Surgeons New Approaches for ALL Andrew Lipsky, MD, Assistant Professor of Medicine at CUMC, Columbia University Vagelos College of Physicians and Surgeons Cell Therapies for ALL + AML Ran Reshef, MD, Associate Professor of Medicine at CUMC, Columbia University Vagelos College of Physicians and Surgeons Upon conclusion of this activity, participants will be better able to: Describe promising new therapies for AML/ALL Discuss principles of cell therapies and transplant and when the therapies can be utilized Describe a patient journey from diagnosis to end of treatment

The speakers are Patrick Kerwin (Abate-Shen Lab) and Hanwen Zhang (Zha Lab).

14th Annual Older Adult Poster Forum: Focus on Program Development, Grant Writing  & Community Based OT Practice